"Neoplasm Grading" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
| Descriptor ID |
D060787
|
| MeSH Number(s) |
E01.789.612
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Grading".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Grading".
This graph shows the total number of publications written about "Neoplasm Grading" by people in this website by year, and whether "Neoplasm Grading" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 7 | 7 |
| 2012 | 0 | 21 | 21 |
| 2013 | 1 | 19 | 20 |
| 2014 | 0 | 20 | 20 |
| 2015 | 1 | 26 | 27 |
| 2016 | 1 | 23 | 24 |
| 2017 | 2 | 21 | 23 |
| 2018 | 1 | 22 | 23 |
| 2019 | 4 | 15 | 19 |
| 2020 | 2 | 14 | 16 |
| 2021 | 0 | 9 | 9 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 10 | 10 |
| 2024 | 2 | 5 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Grading" by people in Profiles.
-
Molecular changes driving low-grade serous ovarian cancer and implications for treatment. Int J Gynecol Cancer. 2024 Oct 07; 34(10):1630-1638.
-
Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy. JCO Precis Oncol. 2024 Sep; 8:e2400149.
-
Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma. Gynecol Oncol. 2024 Oct; 189:138-145.
-
Low-grade serous ovarian carcinoma: a brief overview of the histopathologic features and differential diagnosis. Int J Gynecol Cancer. 2024 Jul 01; 34(7):1109-1110.
-
Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma. Cancer J. 2024 May-Jun 01; 30(3):133-139.
-
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials. Urol Oncol. 2024 Aug; 42(8):223-228.
-
Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2-4 Prostate Cancer. Eur Urol. 2024 Jul; 86(1):1-3.
-
A radiomics based method for prediction of prostate cancer Gleason score using enlarged region of interest. BMC Med Imaging. 2023 12 08; 23(1):205.
-
Proposal of Novel Binary Grading Systems for Cervical Squamous Cell Carcinoma. Int J Gynecol Pathol. 2024 May 01; 43(3):203-214.
-
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. J Natl Cancer Inst. 2023 11 08; 115(11):1364-1373.